Do you want to read an article? Please log in or register.
HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants
Type 1 Diabetes
Related content
Type 1 DiabetesType 2 Diabetes
Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
Diabetes Care.
Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Dolan LM, Marcovina S, Linder B, Liese AD, Pop-Busui R, Feldman EL
doi: 10.2337/dc17-0179.
COMMENTED
Glycemic Control
Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
Diabetes Care.
Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG
doi: 10.2337/dc18-0287.
COMMENTED
Diabetes - GeneralType 1 Diabetes
Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial
JAMA.
Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group, Krischer JP, Schatz DA, Bundy B, Skyler JS, Greenbaum CJ
doi: 10.1001/
Type 1 Diabetes
Risk factors for decline in renal function among young adults with type 1 diabetes
J Diabetes Complications.
Schwandt A, Bergis D, Denkinger M, Gollisch KSC, Sandig D, Stingl H, Zimny S, Holl RW
doi: 10.1016/j.jdiacomp.
COMMENTED
Type 2 Diabetes
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy
Diabetes Care.
Grubb AL, McDonald TJ, Rutters F, Donnelly LA, Hattersley AT, Oram RA, Palmer CNA, van der Heijden AA, Carr F, Elders PJM, Weedon MN, Slieker RC, 't Hart LM, Pearson ER, Shields BM, Jones AG
doi: 10.2337/dc18-0431.
COMMENTED
Type 1 DiabetesPediatric Diabetes
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetologia.
Jacobsen LM, Bocchino L, Evans-Molina C, DiMeglio L, Goland R, Wilson DM, Atkinson MA, Aye T, Russell WE, Wentworth JM, Boulware D, Geyer S, Sosenko JM
doi: 10.1007/s00125-019-05047-w.
COMMENTED
Pediatric Diabetes
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results
Pediatr Diabetes.
Winkler C, Haupt F, Heigermoser M, Zapardiel-Gonzalo J, Ohli J, Faure T, Kalideri E, Hommel A, Delivani P, Berner R, Kordonouri O, Roloff F, von dem Berge T, Lange K, Oltarzewski M, Glab R, Szypowska A, Snape MD, Vatish M, Todd JA, Larsson HE, Ramelius A, Kördel JÅ, Casteels K, Paulus J, Ziegler AG, Bonifacio E, GPPAD Study Group.
doi: 10.1111/pedi.12870.
Type 1 DiabetesType 2 DiabetesPediatric Diabetes
Trends in Prevalence of Cardiovascular Risk Factors from 2002-2012 among Youth Early in the Course of Type 1 and Type 2 Diabetes. The SEARCH for Diabetes in Youth Study
Pediatr Diabetes.
Kim G, Divers J, Fino NF, Dabelea D, Lawrence JM, Reynolds K, Bell RA, Mayer-Davis E, Crume T, Pettitt DJ, Pihoker C, Liu L
doi: 10.1111/pedi.12846.
COMMENTED
Type 1 Diabetes
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated with Sodium-Glucose Cotransporter (SGLT) Inhibitors
Diabetes Care.
Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M
doi: 10.2337/dc18-